Overview

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Status:
Completed

Trial end date:
2018-11-09

Target enrollment:

Participant gender:

Summary

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease.

Phase:

Phase 2

Details

Lead Sponsor:

MedImmune LLC